Genmab — Oktober 2015
-
Kun lidt i pension
-
endnu lidt god omtale se video livsbekræftende http://www.tvsyd.dk/artikel/forskere-i-vejle-opfinder-vidundermiddel-mod-kraeft
-
vi nærmere os noget stort, mange gode videoer men se og hør nr. 2 det er et must http://www.onclive.com/peer-exchange/MM-emerging-concepts/evolution-of-diagnostic-and-response-criteria-in-multiple-myeloma
-
Så er dara braking news på lokal tv2 syd - http://www.tvsyd.dk/artikel/forskere-i-vejle-opfinder-vidundermiddel-mod-kraeft
-
-
GILD i medvind pga FDAs warning på AbbVies HepC http://news.investors.com/102215-776928-fda-warns-viekira-can-cause-liver-damange.htm?ven=yahoocp&src=aurlled&ven=yahoo
-
Tak for gode links jkj.
-
Har lagt dem i debatten.
-
Spectrum Pharmaceuticals har nemlig modtaget et såkaldt Complete Reponse Letter for lægemidlet, der er til behandling af multipel myelomatose, knoglemarvskræft. I øvrigt den samme sygdom, som Genmab og partneren Janssen forsøger at få godkendt det helt store håb, lægemiddelkandidaten daratumumab.
-
Hvad var begrundelsen?
-
-
Tak Sukker.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind